Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors

被引:6
作者
Conde, Delio Marques [1 ]
Costa-Paiva, Lucia [2 ]
Martinez, Edson Zangiacomi [3 ]
Pinto-Neto, Aarao Mendes [2 ]
机构
[1] Hosp Maternal & Child Healthcare, Breast Serv, BR-74125120 Goiania, GO, Brazil
[2] Univ Estadual Campinas, Dept Gynecol & Obstet, Campinas, SP, Brazil
[3] Univ Sao Paulo, Dept Social Med, BR-14049 Ribeirao Preto, Brazil
关键词
Breast cancer; Menopause; Bone mass; Osteoporosis; Middle-aged women; POSTMENOPAUSAL WOMEN; FRACTURE RISK; ADJUVANT CHEMOTHERAPY; HEALTH; OSTEOPOROSIS; MASS;
D O I
10.1159/000337763
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this study was to investigate the prevalence of low bone mineral density (BMD) and associated factors in middle-aged breast cancer survivors (BCS). Patients and Methods: A cross-sectional study was conducted with 70 BCS of 45-65 years of age undergoing complete oncology treatment. Logistic regression models were used to identify factors associated with low BMD (osteopenia and osteoporosis taken together as a single group). Results: The mean age of participants was 53.2 +/- 5.9 years. BMD was low at the femoral neck in 28.6% of patients and at the lumbar spine in 45.7%. Body mass index <= 30 kg/m(2) (adjusted odds ratio (OR) 3.43; 95% confidence interval (CI) 1.0-11.3) and postmenopausal status (OR adjusted 20.42; 95% CI 2.0-201.2) were associated with low BMD at the lumbar spine. Femoral neck measurements, age > 50 years (OR 3.41; 95% CI 1.0-11.6), and time since diagnosis > 50 months (OR adjusted 3.34; 95% CI 1.0-11.3) increased the likelihood of low BMD. Conclusion: These findings show that low BMD is common in middle-aged BCS. Factors were identified that may affect BMD in BCS and should be considered when implementing strategies to minimize bone loss in middle-aged women with breast cancer.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 27 条
[1]  
[Anonymous], SEER Cancer Statistics Review 1975-2008
[2]  
Baum M, 2002, LANCET, V359, P2131
[3]  
Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI [10.1097/gme.0b013e3181e617e6, 10.1097/gme.0b013e3181c617e6]
[4]   BONE-MINERAL DENSITY AFTER ADJUVANT CHEMOTHERAPY FOR PREMENOPAUSAL BREAST-CANCER [J].
BRUNING, PF ;
PIT, MJ ;
DEJONGBAKKER, M ;
VANDENENDE, A ;
HART, A ;
VANENK, A .
BRITISH JOURNAL OF CANCER, 1990, 61 (02) :308-310
[5]   Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency? [J].
Cameron, David A. ;
Douglas, Sharon ;
Brown, Janet E. ;
Anderson, Richard A. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) :805-814
[6]   Fracture risk among breast cancer survivors - Results from the Women's Health Initiative Observational Study [J].
Chen, Z ;
Maricic, M ;
Bassford, TL ;
Pettinger, M ;
Ritenbaugh, C ;
Lopez, AM ;
Barad, DH ;
Gass, M ;
LeBoff, MS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) :552-558
[7]   Quality of life in Brazilian breast cancer survivors age 45-65 years:: Associated factors [J].
Conde, DM ;
Pinto-Neto, AM ;
Cabello, C ;
Santos-Sá, D ;
Costa-Paiva, L ;
Martinez, EZ .
BREAST JOURNAL, 2005, 11 (06) :425-432
[8]  
Costa-Paiva Lúcia, 2003, Rev. Bras. Ginecol. Obstet., V25, P507
[9]   Bone loss induced by cancer treatment and its management [J].
Delmas, PD ;
Fontana, A .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (02) :260-262
[10]  
Hosmer DW., 2000, Applied logistic regression, DOI DOI 10.1002/0471722146.CH4